I-125 brachytherapy for prostate cancer linked to small increase in bladder cancer riskMarch 25, 2014Genitourinary Cancer
No benefit from androgen deprivation therapy in localized prostate cancerMarch 25, 2014Genitourinary Cancer
Positive surgical margins do not independently predict prostate cancer mortalityMarch 17, 2014Genitourinary Cancer
At least a third of low-risk cancers get upgraded at prostatectomyFebruary 6, 2014Genitourinary Cancer
Minimizing cancer’s impact on bone with denosumab: current and future perspectivesSeptember 4, 2013Breast CancerGenitourinary CancerPatient & Survivor CareBusiness of Medicine
High-grade prostate adenocarcinoma: survival and disease control after radical prostatectomySeptember 3, 2013Genitourinary CancerBusiness of Medicine
Enzalutamide in castrate-resistant prostate cancer after chemotherapyJuly 3, 2013Genitourinary Cancer
Utilization of radiotherapy services by a palliative care unit: pattern and implicationMay 24, 2013Patient & Survivor CareBreast CancerGastroenterologyGenitourinary CancerHead & Neck/Thyroid Cancers
Malignant phyllodes tumor of the prostate and seminal vesicle: an unusual presentationMay 23, 2013Genitourinary CancerRare Diseases
Measuring priority symptoms in advanced bladder cancer: development and initial validation of a brief symptom indexMay 23, 2013Patient & Survivor CareGenitourinary Cancer
Novel therapies extend life in patients with metastatic prostate cancerApril 10, 2013Genitourinary Cancer
The Development of an eHealth Tool Suite for Prostate Cancer Patients and Their Partners September 11, 2012Genitourinary Cancer
